))
Ep. 9: Women's Health and Biotech: Funding Insights and the Future of Endometriosis Diagnostics
Manage episode 378917525 series 3477952
Content provided by Bethany Corbin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bethany Corbin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of FemInnovation, host Bethany Corbin sits down with Somer Baburek to discuss women's health in the biotech industry and the future of endometriosis diagnosis. Somer is the CEO of Hera Biotech, an early-stage women's health company focused on commercializing a minimally invasive diagnostic for endometriosis. Prior to founding Hera, Somer spent 7 years with the largest life science venture capital fund in San Antonio and served as the Director of Clinical Operations for two of the fund's sister companies. Bethany and Somer discuss why the biotech industry continues to ignore women's health, how to build diagnostic tools without a scientific or medical background, how life sciences VC funds analyze biotech companies, and the ways in which Hera Biotech is revolutionizing the endometriosis field. You won't want to miss this exciting discussion.
RELEVANT LINKS:
- More about Hera Biotech at this website.
- Follow Hera Biotech @LinkedIn and @Instagram.
- Hera Biotech Articles & Features @Linktr.ee.
Connect with Our Guest, Somer Baburek: LINKEDIN
Follow Our Host: WEBSITE | LINKEDIN | INSTAGRAM | ADDITIONAL LINKS
24 episodes
Share
